James R Jobe's most recent trade in National Health Investors, Inc. was a trade of 10,000 Stock Option (Right to Buy) 2025 done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors Inc | James R. Jobe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | James R. Jobe | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.63 per share. | 23 Aug 2024 | 31,289 | 28,690 (0%) | 0% | 78.6 | 2,460,254 | Common Stock - Jointly held with spouse |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 23 Aug 2024 | 25,000 | 39,979 (0%) | 0% | 53.4 | 1,335,250 | Common Stock - Jointly held with spouse |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 25,000 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 23 Aug 2024 | 10,000 | 49,979 (0%) | 0% | 54.7 | 547,300 | Common Stock - Jointly held with spouse |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 23 Aug 2024 | 10,000 | 59,979 (0%) | 0% | 57.8 | 577,600 | Common Stock - Jointly held with spouse |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | R. Jobe James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | James R. Jobe | Director | Purchase of securities on an exchange or from another person at price $ 51.40 per share. | 30 Aug 2023 | 1,000 | 14,979 (0%) | 0% | 51.4 | 51,398 | Common Stock - Jointly held with spouse |
| National Health Investors Inc | James R. Jobe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | James R. Jobe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | James R. Jobe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 25,000 | 25,000 | - | - | Stock Options (Right to Buy) 2-25-2021 |